Massion Serum MALDI Celebrex-Taxotere Study

  • Start Date: 30 Aug 2004
  • Research Drive Directory: /Massion/040830/
    • data (data.txt, data_log10.txt) in in ./data/
    • information (info.txt) is in ./data/
  • Data Type: MassSpec
  • Notes:
  • Status:
    1. 100% Complete.
    2. 100% Complete.
    3. 99% Finalization.
    4. 5% Preparing pre/post data.
    5. PGEM data will be sent later.

Output

  • Q1 Distance: ./distance/top200_all/
  • Q2 Distance: ./distance/top200_training_testing/
  • Q1, Q2 Score summary: ./data/summary.xls
  • Q1, Q2 Eisen summary: ./eisen/eisen.ppt
  • Q1, Q2 Distance graphs: ./data/graphs.xls
  • Q3 Survival: ./survival/all-31 winners/
  • Q3 Survival: ./survival/all-11 winners/

Analysis Requests

  1. PD(28) v PR+SD(17) leave one out analysis
    • Determine if pretreatment serum MALDI MS profiling can predict response to treatment
  2. PD(14 & 14) v PR+SD(9 & 8) training and testing
  3. Survival analysis
    • Begin: Date on study
    • End: Date of death or LDKA
  4. Comparison pre/post-serum
    • Find Celecoxib modified proteins
  5. Analysis with PGEM data

Change Log:

Contact Info:

  • Primary Study Contact Person:

Analysts

Edit | Attach | Print version | History: r14 | r13 < r12 < r11 < r10 | Backlinks | View wiki text | Edit WikiText | More topic actions...
Topic revision: r12 - 22 Oct 2004, WillGray
 

This site is powered by FoswikiCopyright © 2013-2022 by the contributing authors. All material on this collaboration platform is the property of the contributing authors.
Ideas, requests, problems regarding Vanderbilt Biostatistics Wiki? Send feedback